The involvement of TH17 cells, characterized by production of IL-17, has been extensively studied in various cancer entities [22] with previous studies reporting higher TH17 lymphocytes in peripheral blood of patients with NSCLC [23, 24]. This evidence concerns the gene IL17A and cancer.